Search
01/01/2026
Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions
Verdaguer-Rodríguez, M., Comas, J.O., López-Carrilero, R., Díaz-Cutraro, L., Espinosa, V., Ruiz-Delgado, I., Barrigón, M.L., Grasa, E., Pousa, E., González-Higueras, F., Cid, J., Lorente-Rovira, E., Barajas, A., Ochoa, S.. Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions. Archives of Womens Mental Health. 2026; 29(1)DOI:10.1007/s00737-025-01637-3. PMID:41661387. IF:2.700(Q2/4D).
01/12/2025
Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study
Chavarría-Elizondo, P, Tortella-Feliu, M, Fortea, L, De la Peña-arteaga, V, Juaneda-Seguí, A, Martínez-Zalacaín, I, Vilajosana, E, Radua, J, Shackman, AJ, Soriano-Mas, C, Fullana, MA. Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study. STRESS AND HEALTH. 2025; 41(6)DOI:10.1002/smi.70128. PMID:41307189. IF:2.700(Q2/4D).
01/09/2025
Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia
Bioque, M, Llorca-Bofi, V, MacDowell, KS, Amoretti, S, Mezquida, G, Cuesta, MJ, Diaz-Caneja, CM, Ibáñez, A, Segarra, R, González-Pinto, A, Roldán, A, Sáiz, PA, Mané, A, Lobo, A, Martínez-Pinteño, A, Cano-Escalera, G, Berrocoso, E, Bernardo, M. Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia. SCHIZOPHRENIA BULLETIN. 2025; 51(5)DOI:10.1093/schbul/sbaf012. PMID:39977257. IF:4.800(Q1/2D).
23/08/2025
Neural correlates of human fear conditioning and sources of variability in 2199 individuals
Radua, J, Savage, HS, Vilajosana, E, Jamieson, A, Abler, B, Åhs, F, Beckers, T, Cardoner, N, Cisler, JM, Diniz, JB, Bach, DR, Elsenbruch, S, Greening, SG, Holt, DJ, Kaczkurkin, AN, Keil, A, Kindt, M, Koch, K, LaBar, KS, Lam, CL, Larson, CL, Lonsdorf, TB, Merz, CJ, McLaughlin, KA, Neria, Y, Pine, DS, van Reekum, CM, Shackman, AJ, Soriano-Mas, C, Spoormaker, VI, Stout, DM, Straube, B, Straube, T, Tuominen, L, Visser, RM, Ahumada, L, Arolt, V, Batistuzzo, MC, Bazán, PR, Biggs, EE, Cano, M, Chavarría-Elizondo, P, Cooper, SE, Dannlowski, U, de la Peña-arteaga, V, Decross, SN, Domschke, K, Ehlers, MR, Graner, JL, Hamm, AO, Herrmann, MJ, Huggins, AA, Icenhour, A, Juaneda-Seguí, A, Junghoefer, M, Kircher, T, Koelkebeck, K, Kuhn, M, Labrenz, F, Lissek, SM, Lotze, M, Lueken, U, Margraf, J, Martínez-Zalacaín, I, Moeck, R, Morriss, J, Ortuño, M, Pittig, A, Porta-Casteras, D, Richter, J, Ridderbusch, IC, Rief, W, Roesmann, K, Rosén, J, Russmann, AN, Sjouwerman, R, Spohrs, J, Ströhle, A, Suarez-Jimenez, B, Ulrich, M, Wittchen, HU, Zhu, X, Waller, L, Walter, H, Thompson, PM, Bas-Hoogendam, JM, Groenewold, NA, Stein, DJ, van der Wee, NJ, Dunsmoor, JE, Marquand, AF, Harrison, BJ, Fullana, MA. Neural correlates of human fear conditioning and sources of variability in 2199 individuals. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-63078-x. PMID:40849409. IF:15.700(Q1/1D).
19/08/2025
Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain
Saiz-Masvidal, C, De la Peña-Arteaga, V, Bertolín, S, Diez, I, Juaneda-Seguí, A, Martínez-Zalacaín, I, Chavarría-Elizondo, P, Subirà, M, Menchón, JM, Sepulcre, J, Fullana, MA, Soriano-Mas, C. Mapping cross-modal functional connectivity of major neurotransmitter systems in the human brain. Brain Structure & Function. 2025; 230(7)DOI:10.1007/s00429-025-02996-4. PMID:40828212. IF:2.900(Q1/1D).
01/08/2025
Effectiveness of a Post-discharge Phone-Based Smoking Cessation Intervention for Patients with Severe Mental Health Disorders: The 061 Quitmental Randomized Controlled Clinical Trial
Martinez, C, Feliu, A, Saura, J, Nieva, G, Pinet, C, Raich, A, Mondon, S, Barrio, P, Andreu, M, Hernández-Ribas, R, Costa, S, Suelves, JM, Vilaplana, J, Enriquez, M, Alaustre, L, Vilalta, E, Alvarez, JB, Guydish, J, Fernández, E, Ballbè, M. Effectiveness of a Post-discharge Phone-Based Smoking Cessation Intervention for Patients with Severe Mental Health Disorders: The 061 Quitmental Randomized Controlled Clinical Trial. International Journal of Mental Health and Addiction. 2025; 23(4)DOI:10.1007/s11469-024-01254-8. PMID:40936741. IF:2.500(Q2/4D).
01/03/2025
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach
Gil-Berrozpe, GJ, Segura, AG, Sánchez-Torres, AM, Amoretti, S, Giné-Servén, E, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldán, A, Forte, MF, Castro, J, Bergé, D, Rodríguez, N, Ballesteros, A, Mas, S, Cuesta, MJ, Bernardo, M. Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2025; 92DOI:10.1016/j.euroneuro.2024.12.002. PMID:39721378. IF:6.700(Q1/1D).
01/02/2025
Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial
Young, AH, Llorca, PM, Fagiolini, A, Falkai, P, Cardoner, N, Nielsen, RE, Blomqvist, O, Godinov, Y, Rive, B, Diels, J, Mulhern-Haughey, S, Reif, A. Efficacy of esketamine nasal spray over quetiapine extended release over the short and long term: sensitivity analyses of ESCAPE-TRD, a randomised phase IIIb clinical trial. BRITISH JOURNAL OF PSYCHIATRY. 2025; 226(2)DOI:10.1192/bjp.2024.124. PMID:39618237. IF:7.600(Q1/1D).
01/03/2022
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Jansen, WJ, Janssen, O, Tijms, BM, Vos, SJB, Ossenkoppele, R, Visser, PJ, Alcolea D., Amyloid Biomarker Study Grp. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurology. 2022; 79(3)DOI:10.1001/jamaneurol.2021.5216. PMID:35099509. IF:29.000(Q1/1D).
04/10/2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Neumann A, Ohlei O, Küçükali F, Bos IJ, Timsina J, Vos S, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Scheltens P, Teunissen CE, Engelborghs S, Frisoni GB, Blin O, Richardson JC, Bordet R, Lleó A, Alcolea D, Popp J, Marsh TW, Gorijala P, Clark C, Peyratout G, Martinez-Lage P, Tainta M, Dobson RJB, Legido-Quigley C, Van Broeckhoven C, Tanzi RE, Ten Kate M, Lill CM, Barkhof F, Cruchaga C, Lovestone S, Streffer J, Zetterberg H, Visser PJ, Sleegers K, Bertram L. Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.. Genome Medicine. 2023; 15(1)DOI:10.1186/s13073-023-01233-z. PMID:37794492. IF:10.400(Q1/1D).
19/09/2023
Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.
Gasca-Salas C, Trompeta C, López-Aguirre M, Rodríguez Rojas R, Clarimon J, Dols-Icardo O, El Bounasri S, Guida P, Mata-Marín D, Hernández-Fernández F, Marras C, García-Cañamaque L, Plaza de Las Heras I, Obeso I, Vela L, Fernández-Rodríguez B. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease.. JOURNAL OF NEUROIMAGING. 2023; 33(6)DOI:10.1111/jon.13156. PMID:37726927. IF:2.300(Q2/5D).
13/09/2023
CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.
Del Campo M, Vermunt L, Peeters CFW, Sieben A, Hok-A-Hin YS, Lleó A, Alcolea D, van Nee M, Engelborghs S, van Alphen JL, Arezoumandan S, Chen-Plotkin A, Irwin DJ, van der Flier WM, Lemstra AW, Teunissen CE. CSF proteome profiling reveals biomarkers to discriminate dementia with Lewy bodies from Alzheimer´s disease.. Nature Communications. 2023; 14(1)DOI:10.1038/s41467-023-41122-y. PMID:37704597. IF:14.700(Q1/1D).
17/08/2023
Brain connectivity correlates of cognitive dispersion in a healthy middle-aged population: influence of subjective cognitive complaints.
Mulet-Pons L, Solé-Padullés C, Cabello-Toscano M, Abellaneda-Pérez K, Perellón-Alfonso R, Cattaneo G, Solana Sánchez J, Alviarez-Schulze V, Bargalló N, Tormos-Muñoz JM, Pascual-Leone A, Bartrés-Faz D, Vaqué-Alcázar L. Brain connectivity correlates of cognitive dispersion in a healthy middle-aged population: influence of subjective cognitive complaints.. JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES. 2023; 78(11)DOI:10.1093/geronb/gbad114. PMID:37587033. IF:4.800(Q1/1D).
01/06/2025
On the complexity of biomarker-driven diagnoses of Alzheimer's disease
Grasso, SM, Santos-Santos, MA, Clark, AL. On the complexity of biomarker-driven diagnoses of Alzheimer's disease. Journal of Neuropsychology. 2025; 19(2)DOI:10.1111/jnp.12428. PMID:40317662. IF:1.800(Q3/6D).
24/03/2025
Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population
Echeverry-Quiceno, LM, Llambrich, S, Heredia-Lidón, A, Giménez, S, Rozalem-Aranha, M, Inampudi, P, Heuzé, Y, Sevillano, X, Fortea, J, Martinez-Abadias, N, Alzheimers Dis Neuroimaging Initiative. Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general population. FASEB JOURNAL. 2025; 39(6)DOI:10.1096/fj.202403009R. PMID:40123509. IF:4.200(Q1/2D).
01/03/2026
Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration
Garcia-Castro, J, Vandevrede, L, Donohue, MC, Vaqué-Alcázar, L, Rubio-Guerra, S, Selma-González, J, Heuer, HW, Morcillo-Nieto, AO, Franquesa, M, Dols-Icardo, O, Bejanin, A, Belbin, O, Fortea, J, Alcolea, D, Carmona-Iragui, M, Abdelnour, C, Barroeta, I, Santos-Santos, M, Saudinós, MBS, Sala, I, Lleó, A, Gorno-Tempini, ML, Mandelli, ML, Raman, R, Wills, AM, Barragan, E, Litvan, I, Boeve, B, Dickerson, B, Grossman, M, Huey, ED, Irwin, DJ, Pantelyat, A, Tartaglia, C, Rojas, JC, Boxer, AL, Illán-Gala, I. Potential role of MRI to optimize clinical trial design for progressive supranuclear palsy and corticobasal degeneration. JPAD-Journal of Prevention of Alzheimers Disease. 2026; 13(3)DOI:10.1016/j.tjpad.2026.100486. PMID:41581260. IF:7.800(Q1/1D).
01/02/2026
Lessons from the Colombian kindred: rethinking Alzheimer's prevention
Fortea, J, Llibre-Guerra, J, O'Connor, A, Levin, J. Lessons from the Colombian kindred: rethinking Alzheimer's prevention. LANCET NEUROLOGY. 2026; 25(2)DOI:10.1016/S1474-4422(25)00481-8. PMID:41579884. IF:45.500(Q1/1D).
01/01/2026
Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study
Pané, A, Videla, L, Calvet-Mirabent, A, Castro-Barquero, S, Viaplana, J, Vaqué-Alcázar, L, Ibarzabal, A, Rozalem-Aranha, M, Bejanin, A, Moize, V, Vidal, J, De Hollanda, A, Ortega, E, Barroeta, I, Camacho, V, Chiva-Blanch, G, Fortea, J, Jiménez, A. Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study. DIABETES. 2026; 75(1)DOI:10.2337/db25-0595. PMID:41247745. IF:7.500(Q1/1D).
01/01/2026
Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study
Malé, J, Fortea, J, Rozalem-Aranha, M, Martínez-Abadías, N, Sevillano, X. Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study. Pattern Recognition And Image Analysis, Ibpria 2025, Pt Ii. 2026; 15938DOI:10.1007/978-3-031-99568-2_11. PMID:. IF:(Q/D).
12/12/2025
Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group
Ulugut, H, Younes, K, Montembeault, M, Bertoux, M, Irish, M, Kumfor, F, Fumagalli, GG, Samanci, B, Illán-Gala, I, Thompson, JC, Santillo, AF, Englund, E, Waldö, ML, Riedl, L, van den Stock, J, Vandenbulcke, M, Vandenberghe, R, Laforce, R, Ducharme, S, Pressman, PS, Caramelli, P, de Souza, LC, Takada, LT, Gurvit, H, Diehl-Schmid, J, Galimberti, D, Pasquier, F, Weintraub, S, Miller, BL, Sturm, VE, Whitwell, JL, Boeve, B, Rohrer, JD, Piguet, O, Gorno-Tempini, ML, Josephs, KA, Snowden, J, Rowe, JB, Warren, JD, Rankin, KP, Pijnenburg, YAL. Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group. Communications Medicine. 2025; 5(1)DOI:10.1038/s43856-025-01252-4. PMID:41387629. IF:(Q/D).
09/12/2025
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies
Rubio-Guerra, S, Sala, I, Sánchez-Saudinos, MB, Videla, L, Bejanin, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Rami, L, Tort-Merino, A, Castellví, M, Pozueta, A, García-Martínez, M, Gomez-Andrés, D, Lage, C, Lopez-García, S, Sánchez-Juan, P, Balasa, M, Llado, A, Altuna, M, Tainta, M, Arranz, J, Zhu, NL, Alcolea, D, Lleo, A, Fortea, J, Rodríguez, ER, Sánchez-Valle, R, Martínez-Lage, P, Illán-Gala, I. Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025; 17(4)DOI:10.1002/dad2.70223. PMID:41383878. IF:(Q/D).
09/12/2025
Development of amyloid-negative neuropsychological norms using GAMLSS
Rubio-Guerra, S, Sánchez-Saudinos, MB, Sala, I, Videla, L, Bejanin, A, Estanga, A, Ecay-Torres, M, de Luis, CL, Rami, L, Tort-Merino, A, Castellví, M, Pozueta, A, García-Martínez, M, Gomez-Andrés, D, Lage, C, Lopez-García, S, Sánchez-Juan, P, Balasa, M, Llado, A, Altuna, M, Tainta, M, Arranz, J, Zhu, NL, Alcolea, D, Lleo, A, Fortea, J, Rodríguez, ER, Sánchez-Valle, R, Martínez-Lage, P, Illán-Gala, I. Development of amyloid-negative neuropsychological norms using GAMLSS. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2025; 17(4)DOI:10.1002/dad2.70224. PMID:41383879. IF:(Q/D).
01/12/2025
Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease
Andersen, OM, de Waal, MWJ, Monti, G, Tesi, N, Jensen, AMG, De Geus, C, van Spaendonk, R, Vogel, M, Ahmad, S, Amin, N, Amouyel, P, Beecham, GW, Bellenguez, C, Berr, C, Bis, JC, Boland, A, Bossù, P, Bouwman, F, Bras, J, Charbonnier, C, Clarimon, J, Cruchaga, C, Daniele, A, Dartigues, JF, Debette, S, Deleuze, JF, Denning, N, Destefano, AL, Dols-Icardo, O, van Duijn, CM, Farrer, LA, Fernández, MV, van der Flier, WM, Fox, NC, Galimberti, D, Genin, E, Gille, JJP, Grenier-Boley, B, Grozeva, D, Guen, YL, Guerreiro, R, Haines, JL, Holmes, C, Hummerich, H, Ikram, MA, Ikram, MK, Kawalia, A, Kraaij, R, Lambert, JC, Lathrop, M, Lemstra, AW, Lleo, A, Myers, RM, Mannens, MMAM, Marshall, R, Martin, ER, Masullo, C, Mayeux, R, Mead, S, Mecocci, P, Meggy, A, Mol, MO, Nacmias, B, Naj, AC, Napolioni, V, Cochran, JN, Nicolas, G, Pasquier, F, Pastor, P, Pericak-Vance, MA, Pijnenburg, YAL, Piras, F, Quenez, O, Ramirez, A, Raybould, R, Redon, R, Reinders, MJT, Richard, AC, Riedel-Heller, SG, Rivadeneira, F, van Rooij, JGJ, Rousseau, S, Ryan, NS, Sanchez-Juan, P, Schellenberg, GD, Scheltens, P, Schott, JM, Seshadri, S, Sie, D, Sims, R, Sistermans, EA, Sorbi, S, van Swieten, JC, Tijms, B, Uitterlinden, AG, Visser, PJ, Wagner, M, Wallon, D, Wang, LS, Williams, J, Yokoyama, JS, Zarea, A, van der Lee, SJ, Olsen, JG, Hulsman, M, Holstege, H. Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease. Molecular Neurodegeneration. 2025; 20(1)DOI:10.1186/s13024-025-00907-z. PMID:41327266. IF:17.500(Q1/1D).
01/12/2025
Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementias
Barba, L, Bellomo, G, Alcolea, D, Wojdala, AL, Gaetani, L, Fortea, J, Abu-Rumeileh, S, Lleó, A, Parnetti, L, Belbin, O, Otto, M, Oeckl, P. Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementias. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2025; 96(12)DOI:10.1136/jnnp-2025-336189. PMID:40571405. IF:7.500(Q1/1D).
28/11/2025
Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Muñoz-Vendrell, A, Campoy-Díaz, S, Valín-Villanueva, P, Casas-Limón, J, Fernández-Lázaro, I, González-García, N, Santos-Lasaosa, S, Osorio, YG, Gonzalez-Martinez, A, Campdelacreu, J, Portocarrero-Sánchez, L, Sánchez, LMC, Sánchez, SMG, Pérez-de-la-parte, A, Sánchez-Mateos, NM, López-Bravo, A, Mínguez-Olaondo, A, Sánchez-Soblechero, A, Ros, AL, Hernández, CM, López, AA, Layos-Romero, A, Caronna, E, Torres-Ferrús, M, Alpuente, A, Pozo-Rosich, P, Belvís, R, Garcia-Azorin, D, Díaz-de-Terán, J, Guerrero-Peral, AL, Gago-Veiga, AB, Huerta-Villanueva, M. Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response. JOURNAL OF HEADACHE AND PAIN. 2025; 27(1)DOI:10.1186/s10194-025-02239-1. PMID:41315923. IF:7.900(Q1/1D).
10/11/2025
Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome
Huber, H, Arranz, J, Arslan, B, Leuzy, A, Kittel, O, Di Molfetta, G, Benejam, B, Videla, L, Barroeta, I, Soriano, LD, Maure-Blesa, L, Rodríguez-Baz, I, Infante, JEA, Illán-Gala, I, Bejanin, A, Montoliu-Gaya, L, Lleo, A, Carmona-Iragui, M, Alcolea, D, Blennow, K, Zetterberg, H, Fortea, J, Ashton, NJ. Plasma p-tau217 as a biomarker of Alzheimer's disease pathology in individuals with Down syndrome. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-65882-x. PMID:41213934. IF:15.700(Q1/1D).
01/11/2025
BioFace3D: An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans
Heredia-Lidón, A, Echeverry-Quiceno, LM, González, A, Hostalet, N, Pomarol-Clotet, E, Fortea, J, Fatjó-Vilas, M, Martínez-Abadías, N, Sevillano, X. BioFace3D: An end-to-end open-source software for automated extraction of potential 3D facial biomarkers from MRI scans. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE. 2025; 271DOI:10.1016/j.cmpb.2025.109010. PMID:40818363. IF:4.800(Q1/1D).
01/11/2025
Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease
Salvadó, G, Janelidze, S, Bali, D, Dolado, AO, Therriault, J, Brum, WS, Binette, AP, Stomrud, E, Mattsson-Carlgren, N, Palmqvist, S, Coomans, EM, Teunissen, CE, van der Flier, WM, Rahmouni, N, Benzinger, TLS, Gispert, JD, Blennow, K, Dore, V, Feizpour, A, Rowe, CC, Alcolea, D, Fortea, J, Villeneuve, S, Johnson, SC, Rosa-Neto, P, Petersen, RC, Jack, CR, Schindler, SE, Suárez-Calvet, M, Ossenkoppele, R, Hansson, O. Plasma Phosphorylated Tau 217 to Identify Preclinical Alzheimer Disease. JAMA Neurology. 2025; 82(11)DOI:10.1001/jamaneurol.2025.3217. PMID:40952756. IF:21.300(Q1/1D).
01/11/2025
Associations of lifestyle factors with amyloid pathology in persons without dementia
Oomens, JE, Vos, SJB, Maserejian, NN, Boada, M, Didic, M, Engelborghs, S, Fladby, T, van der Flier, WM, Frisoni, GB, Fröhlich, L, Gill, KD, Grimmer, T, Hort, J, Itoh, Y, Iwatsubo, T, Klimkowicz-Mrowiec, A, Landau, SM, Lee, DY, Lleó, A, Martinez-Lage, P, de Mendonça, A, Meyer, PT, Parchi, P, Pardini, M, Parnetti, L, Popp, J, Rami, L, Reiman, EM, Rinne, JO, Rodrigue, KM, Sánchez-Juan, P, Santana, I, Scarmeas, N, Scheltens, P, Skoog, I, Sperling, RA, Stern, Y, Villeneuve, S, Waldemar, G, Wiltfang, J, Zetterberg, H, Alcolea, D, Allegri, RF, Altomare, D, Bateman, RJ, Baiardi, S, Baldeiras, I, Blennow, K, den Braber, A, van Buchem, MA, Byun, MS, Cerman, J, Chen, KW, Chipi, E, Day, GS, Drzezga, A, Ekblad, LL, Förster, S, Fortea, J, Freund-Levi, Y, Frings, L, Guedj, E, Habeck, CG, Handels, R, Hausner, L, Hellwig, S, Jiménez-Bonilla, JF, Juaristi, AI, Kandimalla, R, Kern, S, Kirsebom, BESB, Kornhuber, J, Legdeur, N, Levin, J, Maier, W, Marquié, M, Minatani, S, Morbelli, SD, Mroczko, B, Ntanasi, E, de Oliveira, CR, Orellana, A, Peters, O, Prabhakar, S, Ramakers, IH, Rodríguez-Rodriguez, E, Ruiz, A, Rüther, E, Sakhardande, J, Selnes, P, Silva, D, Soininen, H, Spiru, L, Takeda, A, Teunissen, CE, Tijms, BM, Vermunt, L, Wallin, ÅK, Wiels, W, Yannakoulia, M, Yi, D, Zettergren, A, Ossenkoppele, R, Verhey, FRJ, Visser, PJ, Jansen, WJ. Associations of lifestyle factors with amyloid pathology in persons without dementia. JOURNAL OF ALZHEIMERS DISEASE. 2025; 108(3)DOI:10.1177/13872877251379083. PMID:41234025. IF:3.100(Q2/5D).
01/10/2025
EXTRACELLULAR VESICLES IN CADASIL: EMERGING INSIGHTS INTO PATHOGENESIS AND BIOMARKER POTENTIAL
Bugallo-Casal, A, Muiño, E, Lopez, SB, Villatoro-González, P, Appiani, F, Sala, I, Pérez-Gayol, L, Alonso-Palomar, N, Ameal-Tedin, D, Arias-Rivas, S, Rodríguez-Yáñez, M, Santamaria-Cadavid, M, Rodríguez-Castro, E, Fernández-Cadenas, I, Labandeira-Garcia, JL, Rodriguez-Perez, AI, Campos-Perez, F. EXTRACELLULAR VESICLES IN CADASIL: EMERGING INSIGHTS INTO PATHOGENESIS AND BIOMARKER POTENTIAL. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).
01/10/2025
Cognitive Testing in Down Syndrome: Adapting Tools for Better Dementia Diagnosis
Sandkühler, K, Soriano, LD, Fortea, J, Levin, J. Cognitive Testing in Down Syndrome: Adapting Tools for Better Dementia Diagnosis. JOURNAL OF INTELLECTUAL DISABILITY RESEARCH. 2025; 69(10)DOI:. PMID:. IF:2.000(Q1/1D).
02/12/2025
SynaptopathyDB integrates synaptic proteomes, genetic and phenotypic data to advance research on nervous system disorders
Sorokina, O, Dominic, D, Bayés, A, Armstrong, JD, Grant, SGN. SynaptopathyDB integrates synaptic proteomes, genetic and phenotypic data to advance research on nervous system disorders. Scientific Reports. 2025; 15(1)DOI:10.1038/s41598-025-26969-z. PMID:41330977. IF:3.900(Q1/2D).
25/11/2025
Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins
Reig-Viader, R, del Castillo-Berges, D, Burgas-Pau, A, Arco-Alonso, D, Zerpa-Rios, O, Ramos-Vicente, D, Picañol, J, Castellanos, A, Soto, D, Roher, N, Sindreu, C, Bayés, A. Synaptic proteome diversity is shaped by the levels of glutamate receptors and their regulatory proteins. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-65490-9. PMID:41290593. IF:15.700(Q1/1D).
01/10/2025
GENERATION OF HUMAN IPSC LINES FROM CADASIL PATIENTS WITH DIFFERENT NOTCH3 VARIANT POSITIONS
Bugallo-Casal, A, Muiño, E, Bravo-Garcia, S, Hervella, P, Arias-Rivas, S, Rodríguez-Yáñez, M, Pérez-Gayol, L, Maisterra-Santos, O, Gonzálvez, JP, Appiani, F, Villatoro-González, P, Martorell-Riera, M, Vives-Bauza, C, Fernández-Cadenas, I, Campos-Perez, F. GENERATION OF HUMAN IPSC LINES FROM CADASIL PATIENTS WITH DIFFERENT NOTCH3 VARIANT POSITIONS. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).
01/10/2025
CYP2C19 GENOTYPES AND RELATIONSHIP WITH ON-TREATMENT PLATELET REACTIVITY STATUS AT HIGH AND LOW SHEAR STRESS ON CLOPIDOGREL IN A TIA/ ISCHAEMIC STROKE PATIENT POPULATION IN IRELAND
Ova, IN, Smith, D, Offiah, C, Carol, LL, Mariné-Llorente, L, Cox, D, Ford, G, Norrving, B, Thijs, V, Montaner, J, Collins, R, Ryan, D, Mccarthy, A, Murphy, S, Egan, B, O'Donnell, M, De Borst, G, Zgaga, L, Walsh, C, Kelleher, J, Macey, C, Hennessy, M, Fernández-Cadenas, I, Mccabe, D. CYP2C19 GENOTYPES AND RELATIONSHIP WITH ON-TREATMENT PLATELET REACTIVITY STATUS AT HIGH AND LOW SHEAR STRESS ON CLOPIDOGREL IN A TIA/ ISCHAEMIC STROKE PATIENT POPULATION IN IRELAND. International Journal of Stroke. 2025; 20(2_SUPPL)DOI:. PMID:. IF:8.700(Q1/1D).
01/01/2023
A Longitudinal Clinical Trajectory Analysis Examining the Accumulation of Co-morbidity in People with Type 2 Diabetes (T2D) Compared with Non-T2D Individuals.
Heald A, Qin R, Williams R, Warner-Levy J, Narayanan RP, Fernandez I, Peng Y, Gibson JM, McCay K, Anderson SG, Ollier W. A Longitudinal Clinical Trajectory Analysis Examining the Accumulation of Co-morbidity in People with Type 2 Diabetes (T2D) Compared with Non-T2D Individuals.. Diabetes Therapy. 2023; 14(11)DOI:10.1007/s13300-023-01463-9. PMID:37707702. IF:2.800(Q3/6D).
19/12/2025
OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2
DeDiego, ML, López-Fernández-Sobrino, R, Pedragosa, J, López-García, D, Nogales, A, Durbán, J, Cardona, F, Llucià-Carol, L, Rivero, V, Vazquez-Utrilla, P, Sanchez-Grande, LP, Cobo, M, Lloret, L, Márquez-Kisinousky, L, Ruiz-Jaén, F, Lozano, F, Sibila, O, Faner, R, Castro, P, Domingo, C, Robles, V, Bedini, JL, Rico, V, Aguero, D, Soriano, A, Nalda, AM, Martinez, AP, Colobran, R, Soler-Palacín, P, Serra-Llovich, A, Dietl, B, Arranz, MJ, Dalmau, D, Signes-Costa, J, Gil-Carbonell, J, Todolí, J, Martínez, J, Rojo, S, Fiz-López, A, Arribas, E, Cal-Sabater, P, Bernado, D, Vogel, M, Wiemann, S, Abolhassani, H, Pan-Hammarström, Q, Pujol, A, Su, HC, Lee, D, Zhang, SY, Casanova, JL, Fernández-Cadenas, I, Pérez-Tur, J, Planas, AM. OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2. iScience. 2025; 28(12)DOI:10.1016/j.isci.2025.113966. PMID:41438061. IF:4.100(Q1/2D).
01/11/2021
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
Glasbey, JC, Ademuyiwa, A, Adisa, A, AlAmeer, E, Bravo, AM, Costas-Chavarri, A, Harrison, E, Gomes, GMA, Mann, H, McLean, K, Modolo, M, Morton, D, Ramos-De la Medina, A, Roslani, AC, Seenivasagam, RK, Simoes, JFF, Smart, N, Sullivan, R, Taylor, EH, Nepogodiev, D, Bhangu, AA, Siaw-Acheampong, K, Bywater, E, Chaudhry, D, Dawson, BE, Gujjuri, RR, Heritage, E, Jones, CS, Khatri, C, Khaw, RA, Keatley, JM, Knight, A, Lawday, S, Li, E, Mann, HS, Marson, EJ, McLean, KA, Mckay, SC, Mills, EC, Pellino, G, Picciochi, M, Tiwari, A, Trout, IM, Venn, ML, WWilkin, RJ, Smart, NJ, Evans, JP, Di Saverio, S, Vallance, A, Vimalchandran, D, Kamarajah, SK, Evans, RPT, Mckay, S, Isaac, J, Edwards, J, Coonar, AS, Marchbank, A, Layton, GR, Patel, A, Brunelli, A, Ford, S, Gronchi, A, Almond, M, Tirotta, F, Dumitra, S, Price, SJ, Fountain, DM, Hutchinson, P, Marcus, HJ, Piper, RJ, Lippa, L, Servadei, F, Esene, I, Freyschlag, C, Neville, I, Rosseau, G, Schaller, K, Demetriades, AK, Robertson, F, Alamri, A, Schache, AG, Winter, SC, Ho, M, Nankivell, P, Biel, JR, Batstone, M, Ganly, I, Wilkins, A, Singh, JK, Thekinkattil, D, Fotopoulou, C, Leung, EYL, Khan, T, Chiva, L, Sehouli, J, Fagotti, A, Cohen, P, Gutelkin, M, Ghebre, R, Konney, T, Pareja, R, Bristow, R, Dowdy, S, Shylasree, TS, Ng, J, Fujiwara, K, Lamb, B, Narahari, K, McNeill, A, Colquhoun, A, McGrath, JS, Bromage, S, Barod, R, Kasivisvanathan, V, Klatte, T, Abbott, TEF, Abukhalaf, S, Adamina, M, Ademuyiwa, AO, Agarwal, A, Akkulak, M, Alameer, E, Alderson, D, Alakaloko, F, Albertsmeier, M, Alser, O, Alshaar, M, Alshryda, S, Arnaud, AP, Augestad, KM, Ayasra, F, Azevedo, J, Bankhead-Kendall, BK, Barlow, E, Beard, D, Benson, RA, Blanco-Colino, R, Brar, A, Breen, KA, Bretherton, C, Buarque, IL, Burke, J, Caruana, EJ, Chaar, M, Chakrabortee, S, Christensen, P, Cox, D, Cukier, M, Cunha, MF, Davidson, GH, Desai, A, Edwards, JG, Drake, TM, Elhadi, M, Emile, S, Farik, S, Fiore, M, Fitzgerald, JE, Garmanova, T, Gallo, G, Ghosh, D, Grecinos, G, Griffiths, EA, Gruendl, M, Halkias, C, Harrison, EM, Hisham, I, Hutchinson, PJ, Hwang, S, Isik, A, Jenkinson, MD, Jonker, P, Kaafarani, HMA, Keller, D, Kolias, A, Kruijff, S, Lawani, I, Lederhuber, H, Leventoglu, S, Litvin, A, Loehrer, A, Loffler, MW, Lorena, MA, Modolo, MM, Major, P, Martin, J, Mashbari, HN, Mazingi, D, Metallidis, S, Minaya-Bravo, A, Mohan, HM, Moore, R, Moszkowicz, D, Moug, S, Ng-Kamstra, JS, Maimbo, M, Negoi, I, Niquen, M, Ntirenganya, F, Olivos, M, Oussama, K, Outani, O, Parreno-Sacdalanm, MD, Pata, F, Rivera, CJP, Pinkney, TD, van der Plas, W, Pockney, P, Qureshi, A, Radenkovic, D, Richards, T, Roberts, K, Roslani, AC, Rutegard, M, Segura-Sampedro, JJ, Santos, I, Satoi, S, Sayyed, R, Schache, A, Schnitzbauer, AA, Seyi-Olajide, JO, Sharma, N, Shaw, CA, Shaw, R, Shu, S, Soreide, K, Spinelli, A, Stewart, GD, Sund, M, Sundar, S, Tabiri, S, Townend, P, Tsoulfas, G, van Ramshorst, GH, Vidya, R, Warren, OJ, Wedderburn, D, Wright, N, Booth, L, Barker, M, Barker, N, Cooke, S, Dore, S, Horwood, N, Runigamugabo, E, Weir, CT, Dajti, I, Allemand, C, Boccalatte, LA, Figari, M, Lamm, M, Larranaga, J, Marchitelli, C, Noll, F, Odetto, D, Perrotta, M, Saadi, J, Zamora, L, Ballester, AM, Tapper, KE, Zeff, N, Valenzuela, JI, Alurralde, C, Anastasio, J, Apas, PDA, Caram, EL, Eskinazi, D, Mendoza, JP, Usandivaras, M, Badra, R, Esteban, A, Garcia, JS, Garcia, PM, Gerchunoff, JI, Lucchini, SM, Nigra, MA, Vargas, L, Hovhannisyan, T, Stepanyan, A, Vasey, CE, Watson, EGR, Ip, C, Kealey, J, Lim, CSH, Sengupta, S, Ward, S, Wong, E, Gould, T, Gourlay, R, Griffiths, B, Gananadha, S, McLaren, M, Cecire, J, Joshi, N, Salindera, S, Sutherland, A, Ahn, JH, Charlton, G, Chen, S, Gauri, N, Hayhurst, R, Jang, S, Jia, F, Mulligan, C, Yang, W, Ye, G, Zhang, H, Ballal, M, Gibson, D, Hayne, D, McMillan, H, Moss, J, Pugliese, MJ, Richards, T, Seow, YTN, Thian, A, Viswambaram, P, Vo, UG, Bennetts, J, Bright, T, Brooke-Smith, M, Fong, R, Gricks, B, Huang, L, Lam, YH, Nathan, A, Ong, BS, Ooi, E, Szpytma, M, Watson, D, Bagraith, K, Caird, S, Chan, E, Dawson, C, Ho, D, Hui, N, Izwan, S, Jeyarajan, E, Jordan, S, Liang, R, Lim, A, Nolan, GJ, Oar, A, Parker, D, Puhalla, H, Quennell, A, Rutherford, L, Sommerville, C, Townend, P, Von, PM, Wullschleger, M, Dawson, AC, Drane, A, Blatt, A, Cope, D, Egoroff, N, Fenton, M, Gani, J, Lott, N, Pockney, P, Shugg, N, Balagué C., Moral, A, Sánchez-López, A., Targarona, E, Aldawbali, M.. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. LANCET ONCOLOGY. 2021; 22(11)DOI:10.1016/S1470-2045(21)00493-9. PMID:34624250. IF:54.433(Q1/1D).
01/09/2021
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
Nepogodiev, D., Martin Arnau A.B., Zwittag, Paul. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. BJS-BRITISH JOURNAL OF SURGERY. 2021; 108(9)DOI:10.1093/bjs/znab101. PMID:33761533. IF:11.782(Q1/1D).
05/11/2022
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
Glasbey, JC, Abbott, TEF, Ademuyiwa, A, Adisa, A, AlAmeer, E, Alshryda, S, Arnaud, AP, Bankhead-Kendall, B, Abou Chaar, MK, Chaudhry, D, Costas-Chavarri, A, Cunha, MF, Davies, JI, Desai, A, Elhadi, M, Fiore, M, Fitzgerald, JE, Fourtounas, M, Fowler, AJ, Futaba, K, Gallo, G, Ghosh, D, Gujjuri, RR, Hamilton, R, Haque, P, Harrison, EM, Hutchinson, P, Hyman, G, Isik, A, Jayarajah, U, Kaafarani, HMA, Kadir, B, Lawani, I, Lederhuber, H, Li, E, Loffler, MW, Lorena, MA, Mann, H, Martin, J, Mazingi, D, McClain, CD, McLean, KA, Meara, JG, Ramos-De La Medina, A, Mengesha, M, Minaya, A, Modolo, MM, Moore, R, Morton, D, Nepogodiev, D, Ntirenganya, F, Pata, F, Pearse, R, Picciochi, M, Pinkney, T, Pockney, P, van Ramshorst, GH, Richards, T, Roslani, AC, Satoi, S, Sayyed, R, Shaw, R, Simoes, JFF, Smart, N, Sulliva, R, Sund, M, Sundar, S, Tabiri, S, Taylor, EH, Venn, ML, Wickramasinghe, D, Wright, N, Yip, SBS, Bhangu, A, Sánchez-Cabús S., COVID surg collaborative. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries. LANCET. 2022; 400(10363)DOI:10.1016/S0140-6736(22)01846-3. PMID:36328042. IF:168.900(Q1/1D).